High-Purity Atorvastatin Calcium Powder for Pharmaceutical Applications
Your trusted source for pharmaceutical-grade lipid-regulating agents to manage cholesterol levels effectively.
Get a Quote & SampleProduct Core Value
Atorvastatin Calcium Powder
Atorvastatin calcium is a potent lipid regulator primarily acting on the liver to reduce cholesterol synthesis and enhance low-density lipoprotein receptor synthesis. This leads to reduced blood cholesterol and LDL cholesterol levels, with a moderate decrease in serum triglyceride levels and an increase in HDL cholesterol. Its high purity and pharmaceutical grade make it ideal for your formulations.
- Discover the benefits of high purity atorvastatin calcium for effective cholesterol management.
- Explore pharmaceutical grade atorvastatin calcium, crucial for lipid regulator applications.
- Learn about reducing cholesterol synthesis with our premium atorvastatin calcium powder.
- Source your atorvastatin calcium from a reliable supplier in China for your pharmaceutical needs.
Key Advantages
Exceptional Purity
Benefit from our atorvastatin calcium powder with over 99% purity, ensuring optimal efficacy and safety in pharmaceutical preparations.
Reliable Supply Chain
As a leading atorvastatin calcium supplier in China, we ensure timely delivery and consistent quality for your production needs.
Pharmaceutical Grade Quality
Our product meets stringent pharmaceutical grade standards, supporting your goals of reducing cholesterol synthesis effectively.
Key Applications
Cholesterol Management
Utilize high purity atorvastatin calcium for effective management of hypercholesterolemia and related cardiovascular conditions.
Lipid Regulation
Leverage the lipid-regulating properties of atorvastatin calcium powder in developing advanced therapeutic agents.
Pharmaceutical Intermediates
Employ this pharmaceutical grade material as a key intermediate in the synthesis of various cardiovascular drugs.
Drug Development
Our atorvastatin calcium powder is an excellent choice for research and development in new cholesterol-lowering medications.